Drugs

, Volume 27, Issue 3, pp 271–277 | Cite as

Angiotensin-Converting Enzyme Inhibitors in the Treatment of Hypertension

  • C. I. Johnston
  • L. Arnolda
  • M. Hiwatari
Practical Therapeutics

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Atkinson, A.B.; Lever, A.F.; Brown, J.J. and Robertson, J.J.S.: Combined treatment of severe intractable hypertension with captopril and diuretic. Lancet 2: 105–108 (1980).PubMedCrossRefGoogle Scholar
  2. Brunner, H.R.; Gavras, H.; Waeber, B. et al.: Clinical use of an orally acting converting enzyme inhibitor: Captopril. Hypertension 2: 558–566 (1980).PubMedCrossRefGoogle Scholar
  3. Ferguson, R.K.; Vlasses, P.H.; Koplin, J.R. et al.: Captopril in severe treatment resistant hypertension. American Heart Journal 99: 579–585 (1980).PubMedCrossRefGoogle Scholar
  4. Heel, R.C.; Brogden, R.N.; Speight, T.M. and Avery, G.S.: Captopril: A preliminary review of its pharmacological properties and therapeutic efficacy. Drugs 20: 409–452 (1980).PubMedCrossRefGoogle Scholar
  5. Hollenberg, N.K.: Converting enzyme inhibition: Implications for renal perfusion and function. Clinical and Experimental Pharmacology and Physiology 7 (Suppl.): 73–79 (1982).Google Scholar
  6. Johnston, C.I.; McGrath, B.P.; Matthews, P.G. and Jackson, B.: Treatment of hypertension with angiotensin converting enzyme inhibitors. Clinical and Experimental Pharmacology and Physiology 7 (Suppl.): 135–144 (1982).Google Scholar
  7. Knill, J.B.: The development of captopril and its role in the treatment of hypertension. Clinical and Experimental Pharmacology and Physiology 7 (Suppl.): 63–72 (1982).Google Scholar
  8. Lopez-Obejero, J.A.; Saal, J.; D’Angelo, W.A. et al.: Reversal of vascular and renal crises of scleroderma by oral angiotensin converting enzyme blockade. New England Journal of Medicine 300: 1417–1419 (1979).CrossRefGoogle Scholar
  9. Laragh, J.J.; Case, D.B.; Atlas, S.A. and Sealey, J.E.: Captopril compared with other antirenin system agents in hypertensive patients: Its triphasic effects on blood pressure and its use to identify and treat the renin factor. Hypertension 2: 586–593 (1980).PubMedCrossRefGoogle Scholar
  10. McGrath, B.P.; Matthews, P.G. and Johnston, C.I.: Use of captopril in the diagnosis of renal hypertension. Australia and New Zealand Journal of Medicine 11: 359–363 (1981).CrossRefGoogle Scholar
  11. Ondetti, M.A.; Rubin, B. and Cushman, D.W.: Design of specific inhibitors of angiotensin-converting enzyme: New class of orally active antihypertensive agents. Science 196: 441–444 (1977).PubMedCrossRefGoogle Scholar
  12. Vaughan, E.D.; Carey, R.M.; Ayers, C.R. and Peach, M.J.: Haemodialysis-resistant hypertension: Control with an orally active inhibitor of angiotensin-converting enzyme. Journal of Clinical Endocrinology and Metabolism 48: 869–871 (1979).PubMedCrossRefGoogle Scholar
  13. Veterans’ Administration Co-operative Study Group on Antihypertensive Agents: Racial differences in response to low-dose captopril are abolished by the addition of hydrochlorothiazide. British Journal of Clinical Pharmacology 14: 975–1015 (1982).Google Scholar
  14. Vidt, D.G.; Bravo, E.L. and Fouad, F.M.: Captopril. New England Journal of Medicine 306: 214–219 (1982).PubMedCrossRefGoogle Scholar
  15. Wauters, J.P.; Waeber, B.; Brunner, H.R. et al.: Uncontrollable hypertension in patients on hemodialysis: Long term treatment with captopril and salt subtraction. Clinical Nephrology 16: 86–92 (1981).PubMedGoogle Scholar
  16. White, N.J.; Yahaja, H.; Rajapopalan, B. et al.: Captopril and frusemide in severe drug-resistant hypertension. Lancet 2: 108–110 (1980).PubMedCrossRefGoogle Scholar
  17. Zimmerman, B.G.: Adrenergic facilitation by angiotensin — does it serve a physiological function? Clinical Science 60: 343–348 (1981).PubMedGoogle Scholar

Copyright information

© ADIS Press Limited 1984

Authors and Affiliations

  • C. I. Johnston
    • 1
  • L. Arnolda
    • 1
  • M. Hiwatari
    • 1
  1. 1.Department of MedicineMonash University, Prince Henry’s HospitalMelbourneAustralia

Personalised recommendations